Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Cancer Gene Therapy|January 22, 2003
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cellsDaniela Tavian, Alessandro Salvi, Giuseppina De Petro, et al.
Biological Chemistry|April 4, 2002
Induction of fibronectin mRNA by urokinase- and tissue-type plasminogen activator in human skin fibroblasts: differential role of u-PA and t-PA at the fibronectin protein levelGiuseppina De Petro, Daniela Tavian, Eleonora Marchina, et al.
European Journal of Translational Myology|May 14, 2021
Recurrent N209* ABHD5 mutation in two unreported families with Chanarin Dorfman SyndromeDaniela Tavian, Murat Durdu, Corrado Angelini, et al.
Molecular Genetics and Metabolism|May 10, 2015
Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblingsSara Missaglia, Elisabetta Tasca, Corrado Angelini, et al.
European Journal of Translational Myology|June 6, 2020
Correlation between ETFDH mutations and dysregulation of serum myomiRs in MADD patientsSara Missaglia, Valentina Pegoraro, Roberta Marozzo, et al.
Muscle & Nerve|November 16, 2019
MiRNAs as biomarkers of phenotype in neutral lipid storage disease with myopathyValentina Pegoraro, Sara Missaglia, Roberta Marozzo, et al.
Lipids in Health and Disease|December 30, 2019
A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findingsAli Haydar Eskiocak, Sara Missaglia, Laura Moro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 13, 2015
Inhibition of Anthracycline Alcohol Metabolite Formation in Human Heart Cytosol: A Potential Role for Several Promising DrugsAlvaro Mordente, Andrea Silvestrini, Giuseppe Ettore Martorana, et al.
Psychiatric Genetics|October 25, 2021
Influence of 5-HTTLPR polymorphism on postpartum depressive and posttraumatic symptomsMarta Landoni, Sara Missaglia, Daniela Tavian, et al.
Expert Opinion on Investigational Drugs|July 3, 2013
Therapies currently in Phase II trials for malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Daniela Tavian, et al.
Pageof 7